estradiol vaginal ring
Selected indexed studies
- Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception. (Am Fam Physician, 2020) [PMID:32412221]
- Complication of a 2-mg estradiol vaginal ring: fibrotic vaginal adhesion. (Menopause, 2014) [PMID:24937026]
- Vaginal ring contraception. (Contraception, 2011) [PMID:21237335]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Contemporary Hormonal Contraception and the Risk of Breast Cancer. (2017) pubmed
- Complication of a 2-mg estradiol vaginal ring: fibrotic vaginal adhesion. (2014) pubmed
- Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review. (2003) pubmed
- The clinical platform for the 17beta-estradiol vaginal releasing ring. (1998) pubmed
- Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade. (1998) pubmed
- Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception. (2020) pubmed
- Vaginal ring contraception. (2011) pubmed
- Contraceptive vaginal ring. (2007) pubmed
- A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year. (2020) pubmed
- The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring. (2007) pubmed